It is a pharma private limited company based in Mangalore, Karnataka, India, established in 2021.
2021 | Mangalore, Karnataka, India | ActiveNasbio Pharma Private Limited, a active private limited company, was established on 12 July 2021 in Mangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24110KA2021PTC149340. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Shameer Mohammed (Director), Mohammed Ashif Jokatte Hasanabba (Director), Rainaz (Director). Past directors included Rehana Shameer Mohammad, Mohammed Nawaz. It holds ₹6.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Door No. 16-2-73/20, Second Floor,Bavas Complex,, Bavas Complex, T.S. No. 738/2A, Kankanady Bypass Road, Mangalore, Mangalore, Karnataka, 575002.
U24110KA2021PTC149340
149340
12 July 2021
₹0.10 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Nasbio Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shameer Mohammed | Director | 12 Jul 2021 | Current |
| Mohammed Ashif Jokatte Hasanabba | Director | 12 Jul 2021 | Current |
| Rainaz | Director | 17 Dec 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Dec 2024 | Past |
| Pramod Abcsdd | Director | 09 Jan 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nasbio Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 2630.38% increase. The company also saw a slight improvement in profitability, with a 6.8% increase in profit. The company's net worth observed a substantial decline by a decrease of 165.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Nasbio Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹6,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Mar 2024 | State Bank Of India | ₹6.50 M | Open |
Explore comprehensive loan charge details -
Nasbio Pharma has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nasbio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nasbio Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rainaz was appointed as a Director was appointed as a Director on 17 Dec 2024 & has been associated with this company since 1 year . was completed.
The activity Nasbio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Nasbio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
Progress on A charge with State Bank Of India amounted to Rs. 6.50 M with Charge ID 100878981 was registered on 06 Mar 2024. was documented.
Shameer Mohammed was appointed as a Director was appointed as a Director on 12 Jul 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.
The activity Mohammed Ashif Jokatte Hasanabba was appointed as a Director was appointed as a Director on 12 Jul 2021 & has been associated with this company since 4 years 5 months . was completed.
The CIN of Nasbio Pharma Private Limited is U24110KA2021PTC149340.
Nasbio Pharma Private Limited is headquartered at Door No. 16-2-73/20, Second Floor,Bavas Complex,, Bavas Complex, T.S. No. 738/2A, Kankanady Bypass Road, Mangalore, Mangalore, Karnataka, 575002.
Nasbio Pharma Private Limited was incorporated on 12 July 2021.
The current directors of Nasbio Pharma Private Limited are
The primary industry of Nasbio Pharma Private Limited is Trade.
Nasbio Pharma Private Limited is unlisted.
The authorized capital of Nasbio Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Nasbio Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX